Cargando…
Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159149/ https://www.ncbi.nlm.nih.gov/pubmed/35665408 http://dx.doi.org/10.3389/pore.2022.1610517 |
| _version_ | 1784718990421000192 |
|---|---|
| author | Deme, Daniel Kovacs, Sandor Telekes, Andras |
| author_facet | Deme, Daniel Kovacs, Sandor Telekes, Andras |
| author_sort | Deme, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9159149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91591492022-06-02 Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination Deme, Daniel Kovacs, Sandor Telekes, Andras Pathol Oncol Res Pathology and Oncology Archive Frontiers Media S.A. 2022-05-18 /pmc/articles/PMC9159149/ /pubmed/35665408 http://dx.doi.org/10.3389/pore.2022.1610517 Text en Copyright © 2022 Deme, Kovacs and Telekes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pathology and Oncology Archive Deme, Daniel Kovacs, Sandor Telekes, Andras Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title | Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title_full | Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title_fullStr | Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title_full_unstemmed | Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title_short | Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination |
| title_sort | corrigendum: overall survival prediction of advanced cancer patients by selection of the most significant baseline serum biomarker combination |
| topic | Pathology and Oncology Archive |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159149/ https://www.ncbi.nlm.nih.gov/pubmed/35665408 http://dx.doi.org/10.3389/pore.2022.1610517 |
| work_keys_str_mv | AT demedaniel corrigendumoverallsurvivalpredictionofadvancedcancerpatientsbyselectionofthemostsignificantbaselineserumbiomarkercombination AT kovacssandor corrigendumoverallsurvivalpredictionofadvancedcancerpatientsbyselectionofthemostsignificantbaselineserumbiomarkercombination AT telekesandras corrigendumoverallsurvivalpredictionofadvancedcancerpatientsbyselectionofthemostsignificantbaselineserumbiomarkercombination |